May 05, 2016 8:29 PM ET


Company Overview of Aptalis Pharma S.r.l.

Executive Profile

Aleksandar Erdeljan

Non Executive Director, Aptalis Pharma S.r.l.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 7 different industries.

See Board Relationships


Mr. Aleksandar Erdeljan, Alex, served as Consultant of Blackstone Healthcare Advisors and Special Advisor of Blackstone Healthcare Advisors at The Blackstone Group. Mr. Erdeljan serves as a founding member of Blackstone Healthcare Partners LLC. Mr. Erdeljan is responsible for identifying, sourcing, and analyzing, transactions involving opportunities in health care, with special focus on pharmaceutical technologies and outsourcing services for the pharmaceutical industry. ...

Corporate Headquarters

Via Martin Luther King, 13
Milan, Milan 20060


Phone: 39 02 954281
Fax: 39 02 95 74 50 12

Board Members Memberships

Non Executive Director
Non-Executive Director


IMD International
Bachelor's Degree
Univerzitet u Beogradu
Univerzitet u Beogradu

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Aptalis Pharma S.r.l., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at